Connect Biopharma Holdings Limited (CNTB)
USD 0.98
(-5.23%)
USD 0.98
(-5.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 988 Thousand | 1.03 Million | - | - | - |
| Gross Profit | -988 Thousand | -1.03 Million | - | - | - |
| Operating Expenses | 62.07 Million | 114.68 Million | 97.58 Million | 29.36 Million | 16.43 Million |
| Selling, General and Administrative Expenses | 13.52 Million | 20.36 Million | 19.22 Million | 7.31 Million | 1.4 Million |
| Research and Development Expenses | 51.91 Million | 95.25 Million | 81.34 Million | 23.12 Million | 15.43 Million |
| Other Expenses | -4.35 Million | -940.31 Thousand | -2.98 Million | -1.07 Million | -411.43 Thousand |
| Cost and Expenses | 62.07 Million | 114.68 Million | 97.58 Million | 29.36 Million | 16.43 Million |
| Operating Income | -62.07 Million | -117.66 Million | -99.15 Million | -30.29 Million | -15.99 Million |
| Interest Expense | - | 21.03 Thousand | 6909.14 | 6433.98 | 7689.09 |
| Income Tax Expense | 120 Thousand | 297.51 Thousand | 266.47 Thousand | 934.45 Thousand | -442.48 Thousand |
| Earnings before Tax | -59.38 Million | -116.11 Million | -204.93 Million | -119.36 Million | -24.46 Million |
| Net Income | -59.5 Million | -116.41 Million | -205.2 Million | -120.3 Million | -24.02 Million |
| Earnings Per Share Basic | -1.08 | -14.50 | -25.00 | -14.45 | -3.02 |
| Earnings Per Share Diluted | -1.08 | -14.50 | -25.00 | -14.45 | -3.02 |
| Weighted Average Shares Outstanding | 55.06 Million | 55.04 Million | 52.27 Million | 53.94 Million | 55.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.06 Million | 55.04 Million | 52.27 Million | 53.94 Million | 55.81 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -58.37 Million | -111.3 Million | -204.93 Million | -118.2 Million | -24.78 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 12.05 Million | 12.05 Million | - | - | - | - |
| Cost of Revenue | 476 Thousand | - | - | 988 Thousand | - | 506.12 Thousand |
| Gross Profit | 11.58 Million | 12.05 Million | - | -988 Thousand | - | -506.12 Thousand |
| Operating Expenses | 8.4 Million | 8.4 Million | 16.16 Thousand | 65.44 Million | 16.61 Thousand | 34.33 Million |
| Selling, General and Administrative Expenses | 3.71 Million | 3.71 Million | 3293.12 | - | 3404.88 | 7.6 Million |
| Research and Development Expenses | 6.65 Million | 6.65 Million | 12.89 Thousand | - | 13.25 Thousand | 26.73 Million |
| Other Expenses | -1.96 Million | -1.96 Million | - | - | - | - |
| Cost and Expenses | 8.4 Million | 8.4 Million | 16.16 Thousand | 66.42 Million | 16.61 Thousand | 34.84 Million |
| Operating Income | 3.65 Million | 3.65 Million | -16.12 Thousand | -66.42 Million | -16.58 Thousand | -34.84 Million |
| Interest Expense | 10 Thousand | - | - | - | - | 10.38 Thousand |
| Income Tax Expense | 30 Thousand | 30 Thousand | 28.34 | 120 Thousand | 29.23 | 64.78 Thousand |
| Earnings before Tax | 3.85 Million | 3.85 Million | -14.77 Thousand | -59.38 Million | -15.19 Thousand | -30.51 Million |
| Net Income | 3.82 Million | 3.82 Million | -14.8 Thousand | -59.5 Million | -15.22 Thousand | -30.58 Million |
| Earnings Per Share Basic | 0.07 | 0.07 | -0.27 | - | -0.28 | -0.56 |
| Earnings Per Share Diluted | 0.07 | 0.07 | -0.27 | - | -0.28 | -0.56 |
| Weighted Average Shares Outstanding | 55.14 Million | 55.14 Million | 55.08 Million | 55.06 Million | 55.08 Million | 55.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.55 Million | 55.55 Million | 55.08 Million | 55.06 Million | 55.08 Million | 55.05 Million |
| Gross Margin | 0.96 | 1.00 | - | - | - | - |
| EBIT Margin | 0.26 | 0.26 | - | - | - | - |
| Profit Margin | 0.32 | 0.32 | - | - | - | - |
| EBITDA | 3.14 Million | 3.14 Million | -15.94 Thousand | - | -16.4 Thousand | -34.33 Million |
| Earnings Before Tax Margin | 0.30 | 0.30 | - | - | - | - |
MKGP
EORBF
ENGQF
COTQF
RNC
600691